SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-12-059324
Filing Date
2012-11-05
Accepted
2012-11-05 09:51:39
Documents
19
Period of Report
2012-11-05
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v327380_8k.htm 8-K 15998
2 EXHIBIT 99.1 v327380_ex99-1.htm EX-99.1 16298
3 EXHIBIT 99.2 v327380_ex99-2.htm EX-99.2 16766
4 GRAPHIC image_001.jpg GRAPHIC 108407
5 GRAPHIC image_002.jpg GRAPHIC 423971
6 GRAPHIC image_003.jpg GRAPHIC 191645
7 GRAPHIC image_004.jpg GRAPHIC 143337
8 GRAPHIC image_005.jpg GRAPHIC 77149
9 GRAPHIC image_006.jpg GRAPHIC 140600
10 GRAPHIC image_007.jpg GRAPHIC 220514
11 GRAPHIC image_008.jpg GRAPHIC 221007
12 GRAPHIC image_009.jpg GRAPHIC 227362
13 GRAPHIC image_010.jpg GRAPHIC 136063
14 GRAPHIC image_011.jpg GRAPHIC 147363
15 GRAPHIC image_012.jpg GRAPHIC 213796
16 GRAPHIC image_013.jpg GRAPHIC 197638
17 GRAPHIC image_014.jpg GRAPHIC 67774
18 GRAPHIC image_015.jpg GRAPHIC 107249
19 GRAPHIC image_016.jpg GRAPHIC 3357
  Complete submission text file 0001144204-12-059324.txt   3672155
Mailing Address 99 HUDSON STREET 5TH FLOOR NEW YORK NY 10013
Business Address 99 HUDSON STREET 5TH FLOOR NEW YORK NY 10013 (212) 554-4388
VENTRUS BIOSCIENCES INC (Filer) CIK: 0001426800 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 8-K | Act: 34 | File No.: 001-35005 | Film No.: 121178787
SIC: 2834 Pharmaceutical Preparations